Literature DB >> 26936974

Catalytic Activities of Tumor-Specific Human Cytochrome P450 CYP2W1 Toward Endogenous Substrates.

Yan Zhao1, Debin Wan1, Jun Yang1, Bruce D Hammock1, Paul R Ortiz de Montellano2.   

Abstract

CYP2W1 is a recently discovered human cytochrome P450 enzyme with a distinctive tumor-specific expression pattern. We show here that CYP2W1 exhibits tight binding affinities for retinoids, which have low nanomolar binding constants, and much poorer binding constants in the micromolar range for four other ligands. CYP2W1 converts all-transretinoic acid (atRA) to 4-hydroxyatRA and all-transretinol to 4-OH all-transretinol, and it also oxidizes retinal. The enzyme much less efficiently oxidizes 17β-estradiol to 2-hydroxy-(17β)-estradiol and farnesol to a monohydroxylated product; arachidonic acid is, at best, a negligible substrate. These findings indicate that CYP2W1 probably plays an important role in localized retinoid metabolism that may be intimately linked to its involvement in tumor development.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26936974      PMCID: PMC4851306          DOI: 10.1124/dmd.116.069633

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  30 in total

Review 1.  Arachidonic acid as a bioactive molecule.

Authors:  A R Brash
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 2.  A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism.

Authors:  F Marks; K Müller-Decker; G Fürstenberger
Journal:  Toxicology       Date:  2000-11-16       Impact factor: 4.221

3.  Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.

Authors:  J Marill; T Cresteil; M Lanotte; G G Chabot
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

4.  Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8.

Authors:  M A Leo; J M Lasker; J L Raucy; C I Kim; M Black; C S Lieber
Journal:  Arch Biochem Biophys       Date:  1989-02-15       Impact factor: 4.013

5.  Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole.

Authors:  E A Dierks; S C Davis; P R Ortiz de Montellano
Journal:  Biochemistry       Date:  1998-02-17       Impact factor: 3.162

6.  The expression of CYP2W1: a prognostic marker in colon cancer.

Authors:  Kristina Stenstedt; Maria Hallstrom; Inger Johansson; Magnus Ingelman-Sundberg; Peter Ragnhammar; David Edler
Journal:  Anticancer Res       Date:  2012-09       Impact factor: 2.480

7.  Abnormal oxidative metabolism of estradiol in women with breast cancer.

Authors:  J Schneider; D Kinne; A Fracchia; V Pierce; K E Anderson; H L Bradlow; J Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Estradiol as an antioxidant: incompatible with its physiological concentrations and function.

Authors:  N Santanam; R Shern-Brewer; R McClatchey; P Z Castellano; A A Murphy; S Voelkel; S Parthasarathy
Journal:  J Lipid Res       Date:  1998-11       Impact factor: 5.922

9.  Retinoic acid: an endogenous compound of human blood. Unequivocal demonstration of endogenous retinoic acid in normal physiological conditions.

Authors:  M G De Ruyter; W E Lambert; A P De Leenheer
Journal:  Anal Biochem       Date:  1979-10-01       Impact factor: 3.365

10.  CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma.

Authors:  Cristina L Ronchi; Silviu Sbiera; Marco Volante; Sonja Steinhauer; Vanessa Scott-Wild; Barbara Altieri; Matthias Kroiss; Margarita Bala; Mauro Papotti; Timo Deutschbein; Massimo Terzolo; Martin Fassnacht; Bruno Allolio
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

View more
  7 in total

Review 1.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

2.  Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents.

Authors:  Aaron G Bart; Goreti Morais; Venu R Vangala; Paul M Loadman; Klaus Pors; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2021-10-04       Impact factor: 3.922

3.  Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancer.

Authors:  Daniela Presa; Syed A Khurram; Amir Z A Zubir; Sneha Smarakan; Patricia A Cooper; Goreti R Morais; Maria Sadiq; Mark Sutherland; Paul M Loadman; James McCaul; Steven D Shnyder; Laurence H Patterson; Klaus Pors
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

4.  CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer.

Authors:  Radhika Aiyappa-Maudsley; Sarah J Storr; Emad A Rakha; Andrew R Green; Ian O Ellis; Stewart G Martin
Journal:  J Pathol Clin Res       Date:  2022-07-28

5.  Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein.

Authors:  Martin J Ronis; Kelly E Mercer; Kartik Shankar; Casey Pulliam; Kim Pedersen; Magnus Ingelman-Sundberg; Simonetta Friso; Derrick Samuelson; Luis Del Valle; Chris Taylor; David A Welsh
Journal:  Chem Biol Interact       Date:  2020-05-14       Impact factor: 5.192

Review 6.  Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies.

Authors:  Smarakan Sneha; Simon C Baker; Andrew Green; Sarah Storr; Radhika Aiyappa; Stewart Martin; Klaus Pors
Journal:  Biomedicines       Date:  2021-03-12

7.  Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery.

Authors:  Alastair F Breen; David Scurr; Maria Letizia Cassioli; Geoffrey Wells; Neil R Thomas; Jihong Zhang; Lyudmila Turyanska; Tracey D Bradshaw
Journal:  Int J Nanomedicine       Date:  2019-12-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.